Wize Pharma shareholders approve reverse stock split
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Israel's Wize Pharma Inc. said its shareholders approved a reverse stock split at a Feb. 19 special meeting.
Under the company's amended certificate of incorporation, the board can effect a reverse stock split by a ratio between 1-for-10 and 1-for-200 at any time before Feb. 19, 2019.
